1. Home
  2. LXU vs ANNX Comparison

LXU vs ANNX Comparison

Compare LXU & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$11.53

Market Cap

880.5M

Sector

Industrials

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.27

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXU
ANNX
Founded
1968
2011
Country
United States
United States
Employees
513
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
880.5M
812.7M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
LXU
ANNX
Price
$11.53
$5.27
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$14.63
$16.50
AVG Volume (30 Days)
662.5K
4.2M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
225.93
N/A
EPS
0.27
N/A
Revenue
$615,208,000.00
N/A
Revenue This Year
$13.69
N/A
Revenue Next Year
N/A
$16,320.74
P/E Ratio
$45.33
N/A
Revenue Growth
17.77
N/A
52 Week Low
$7.09
$2.03
52 Week High
$17.22
$7.18

Technical Indicators

Market Signals
Indicator
LXU
ANNX
Relative Strength Index (RSI) 50.03 46.61
Support Level $11.54 $5.28
Resistance Level $15.56 $5.43
Average True Range (ATR) 0.37 0.47
MACD 0.17 -0.08
Stochastic Oscillator 50.73 22.84

Price Performance

Historical Comparison
LXU
ANNX

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: